Evidence map›Paper›PMID 38496193›Full record

ArticleCureus2024

The Apple Vision Pro as a Neurosurgical Planning Tool: A Case Report.

Joshua Olexa, Annie Trang, Jonathan Cohen, Kevin Kim, Maureen Rakovec, Jordan Saadon, Charles Sansur, Graeme Woodworth, Gary Schwartzbauer, Jacob Cherian

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Joshua OlexaNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Annie TrangNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Jonathan CohenNeurosurgery, Hoth Intelligence, Philadelphia, USA.
Kevin KimNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Maureen RakovecNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Jordan SaadonNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Charles SansurNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Graeme WoodworthNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Gary SchwartzbauerNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
Jacob CherianNeurosurgery, University of Maryland School of Medicine, Baltimore, USA.
National Intelligence University · USUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With its recent release, the Apple Vision Pro (Apple Inc., Cupertino, CA) represents a promising technological advancement of mixed reality in the field of neurosurgery and medicine more broadly. With all new technologies, it is critical to facilitate early use and assessment of the technology to facilitate adoption by the larger medical community. A 44-year-old female with a history of ruptured intracranial aneurysm status post anterior communicating artery aneurysm clipping presented with worsened confusion and intermittent headache. CT imaging revealed evidence of hydrocephalus due to the malfunction of a previous right parietal ventriculoperitoneal (VP) shunt. Prior to the case, the Apple Vision Pro was used in the operating room to visualize and interact with a 3D model of the patient's anatomy for the patient undergoing a VP shunt placement. A visualization of the 3D model through the headset was used to plan the approach and entry point. At the conclusion of the procedure, all clinicians and operating staff who used the technology for planning completed a survey about their initial impressions of the headset. Overall, users felt the 3D models felt realistic (4.5/5), that the display of the user's real-world view felt natural (4.3/5), and that the headset did not cause eye strain or fatigue (4.5/5). The majority of users responded that they would continue to use the headset for cases (4/5). This represents one of the first known clinical uses of the Apple Vision Pro. It is a cutting-edge technology that will likely provide immense value for healthcare providers as it becomes more integrated into clinical care.

Indexed as

appleapple vision proaugmented realitymixed realityneurosurgeryvision pro

Identifiers

PMID38496193
PMCPMC10942844
OpenAlexW4392784067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.